Nemaura Medical
Nemaura Medical is a pioneering medical technology company dedicated to developing affordable, non-invasive, and digital health monitoring solutions. Their flagship product, the sugarBEAT® system, is a wireless, disposable, and minimally invasive continuous glucose monitoring device designed to empower diabetics and improve personal healthcare management. The company aims to expand its innovative offerings into hospital settings and global markets, leveraging strategic partnerships, clinical trials, and regulatory approvals to bring accessible health monitoring tools to a broad audience.
Industries
Nr. of Employees
small (1-50)
Products
Daily-use non-invasive CGM system (wearable adhesive patch + reusable transmitter + mobile app)
A wearable system combining a low-cost disposable adhesive sensor patch with a reusable Bluetooth-enabled transmitter and a medical-grade mobile app to provide frequent glucose readings and trend reports for adjunctive glucose monitoring. The system architecture supports intermittent daily wear and near-real-time sampling intervals (reported at approximately every 5 minutes).
Wellness CGM subscription service with AI analytics (non-regulated positioning in some markets)
A general wellness offering that provides non-invasive glucose readings processed with AI analytics and delivered through a subscription digital service for metabolic health insights and behavioral feedback.
Metabolic health and behavioral-change program integrating intermittent wearable sensing
A structured behavioral-change program that integrates intermittent wearable glucose sensing, mobile logging, educational modules and AI feedback to support weight loss and sustained lifestyle changes (example protocols include biweekly or periodic sensor use to generate insights).
Wearable lactate sensor (development-stage)
A wearable lactate monitoring sensor under development to provide continuous lactate trend data for athletic performance applications and potential clinical monitoring use cases, with integration planned into monitoring platforms pending further development and regulatory approvals.
Continuous wearable temperature monitoring (development-stage)
A wearable sensor capability for continuous multi-day core/body temperature tracking intended to support early infection detection, disease progression monitoring and fertility/ovulation tracking.
Daily-use non-invasive CGM system (wearable adhesive patch + reusable transmitter + mobile app)
A wearable system combining a low-cost disposable adhesive sensor patch with a reusable Bluetooth-enabled transmitter and a medical-grade mobile app to provide frequent glucose readings and trend reports for adjunctive glucose monitoring. The system architecture supports intermittent daily wear and near-real-time sampling intervals (reported at approximately every 5 minutes).
Wellness CGM subscription service with AI analytics (non-regulated positioning in some markets)
A general wellness offering that provides non-invasive glucose readings processed with AI analytics and delivered through a subscription digital service for metabolic health insights and behavioral feedback.
Metabolic health and behavioral-change program integrating intermittent wearable sensing
A structured behavioral-change program that integrates intermittent wearable glucose sensing, mobile logging, educational modules and AI feedback to support weight loss and sustained lifestyle changes (example protocols include biweekly or periodic sensor use to generate insights).
Wearable lactate sensor (development-stage)
A wearable lactate monitoring sensor under development to provide continuous lactate trend data for athletic performance applications and potential clinical monitoring use cases, with integration planned into monitoring platforms pending further development and regulatory approvals.
Continuous wearable temperature monitoring (development-stage)
A wearable sensor capability for continuous multi-day core/body temperature tracking intended to support early infection detection, disease progression monitoring and fertility/ovulation tracking.
Services
Subscription digital program combining intermittent use of wearable glucose sensors with mobile app-based education, AI analytics and personalized coaching to support weight management and metabolic health.
Design and conduct of pilot and multi-center studies with healthcare partners to evaluate sensor performance, user engagement and clinical outcomes, and to generate data for regulatory and reimbursement submissions.
Commercial licensing to regional distributors and support for local market authorization and reimbursement activities, including partner-managed launches.
Coordination with contract manufacturing organizations and joint-venture partners for volume manufacture of sensor patches and transmitter modules, including selection of facilities with appropriate quality systems.
Subscription digital program combining intermittent use of wearable glucose sensors with mobile app-based education, AI analytics and personalized coaching to support weight management and metabolic health.
Design and conduct of pilot and multi-center studies with healthcare partners to evaluate sensor performance, user engagement and clinical outcomes, and to generate data for regulatory and reimbursement submissions.
Commercial licensing to regional distributors and support for local market authorization and reimbursement activities, including partner-managed launches.
Coordination with contract manufacturing organizations and joint-venture partners for volume manufacture of sensor patches and transmitter modules, including selection of facilities with appropriate quality systems.
Expertise Areas
- Non-invasive transdermal biosensor development
- Wearable medical device hardware and transmitter engineering
- Clinical trial design and device performance validation
- Digital health platform development and mobile medical apps
Key Technologies
- Non-invasive transdermal continuous glucose sensing
- Disposable adhesive sensor patches
- Reusable Bluetooth Low Energy transmitter modules
- Mobile medical applications (iOS/Android) with cloud sync
News & Updates
The company expects to launch the CE-approved sugarBEAT® system in Europe later this year through its European licensee, with clinical trials underway for the second-generation wireless skin-patch.
A joint venture with DBJ Jersey aims to market the sugarBEAT® system across Europe, leveraging local expertise and regulatory approvals.
Clinical trials on the second-generation wireless skin-patch are progressing, with CE approval expected mid-year and plans for European launch later this year.
Interim clinical data shows improved accuracy with a reduction in MARD from 18% to 11.8%, demonstrating the system's potential for safe and effective glucose monitoring.
CE mark approval for the non-invasive, flexible continuous glucose monitor sugarBEAT® in Europe.
Development and testing of the second-generation wireless skin-patch for non-invasive glucose monitoring.
The company expects to launch the CE-approved sugarBEAT® system in Europe later this year through its European licensee, with clinical trials underway for the second-generation wireless skin-patch.
A joint venture with DBJ Jersey aims to market the sugarBEAT® system across Europe, leveraging local expertise and regulatory approvals.
Clinical trials on the second-generation wireless skin-patch are progressing, with CE approval expected mid-year and plans for European launch later this year.
Interim clinical data shows improved accuracy with a reduction in MARD from 18% to 11.8%, demonstrating the system's potential for safe and effective glucose monitoring.
CE mark approval for the non-invasive, flexible continuous glucose monitor sugarBEAT® in Europe.
Development and testing of the second-generation wireless skin-patch for non-invasive glucose monitoring.